ArticleNeurosurgical review2026
Endoscopic endonasal surgery for cholesteatomas of the posterior cranial fossa and parasellar region. A challenging pathology for experts.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic endonasal surgery (EES) offers a direct ventral corridor to the skull base, potentially enabling maximal resection of extensive cholesteatomas (epidermoid cysts) in the posterior cranial fossa and parasellar region. However, outcomes and complications specific to this approach require detailed analysis. A retrospective review was conducted on 34 patients who underwent EES for cholesteatomas of the posterior fossa and parasellar region at a single center from 2011 to 2025 year. Extent of resection (near-total > 95%, subtotal 90-95%), complications, and neurological outcomes were analyzed. Near-total resection was achieved in 65% of cases and subtotal in 35%. The most frequent complications were postoperative cerebrospinal fluid (CSF) leakage (23.5%) and meningitis (23.5%; 33.3% in patients with intradural extension). Rates were significantly higher than for other skull base tumors. Only visual symptoms showed consistent postoperative improvement. New or worsened cranial nerve deficits occurred in 12% of cases. Arrested hydrocephalus requiring shunting developed in 14.7% of patients. The endoscopic endonasal approach is one of the surgical options for patients with cholesteatomas involving the posterior cranial fossa and the chiasmatic-sellar region. However, it is associated with a notably higher risk of CSF leakage and meningitis compared to EES for other pathologies, attributable to the lesion's adhesive and inflammatory characteristics. Furthermore, significant recovery of preoperative neurological deficits (except visual) is uncommon. These findings underscore that indications for selecting this approach must be strictly justified, taking into account the risk of complications.
Indexed as
Identifiers
42271088What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.